Atos and Huma, a digital health innovator, has announced a five-year strategic global partnership to move healthcare and clinical trials out of hospitals and people's homes. The partnership will center on Huma's modular platform, which can power digital "home hospitals" nationally and assist pharmaceutical and research industries in running sophisticated worldwide, decentralized clinical trials. The platform is already being used in the United States and Europe to treat illnesses ranging from atrial fibrillation to diabetes to Covid-19.
To accelerate the adoption of Huma's technology, Atos will use its experience in delivering and scaling complex transformation projects. Atos will make an investment of up to €20 million in R&D and go-to-market resources, including dedicated consulting and sales personnel. The R&D investment will accelerate the integration of the Huma platform with other leading clinical platforms and develop a dedicated video module.
The immense pressure put on the world's healthcare systems by the Covid-19 pandemic exposes the flaws of current models, which are already overloaded aging populations and the increased worldwide incidence of chronic conditions. To improve both patient care and the entire efficiency of the care chain, innovation is required. The approach used by Atos and Huma means that patients are monitored outside of the hospital and get early, proactive clinical intervention ahead of need, ultimately optimizing resource use, improving patient outcomes, and reducing long-term healthcare costs.
Early evidence suggests that Huma's service, which is now available nationally in Germany, England, and the UAE, can almost double hospital capacity.
The partnership will use Huma's industry-leading software platform and 40+ patents and Atos' extensive professional service capabilities in digital strategy, change management, and service management.
The 5-year partnership will begin with integration, enabling global go-to-market deployments. Still, it will also combine Atos' expertise in promoting digital adoption, support, and infrastructure with Huma's digital care, clinical trials, and biomarkers. The companies estimate that the combined service will generate €100 million in revenue per year during the first four years.
About Atos
With 105,000 employees and annual revenue of more than € 11 billion, Atos is a global leader in digital transformation. The Group, the European leader in cybersecurity, cloud, and high-performance computing, provides customized end-to-end solutions for all industries in 71 countries. Atos, a pioneer in decarbonization services and products, is dedicated to providing its clients with a safe and decarbonized digital experience. Atos is recognized by the brands Atos and Atos|Syntel.
About Huma
Huma is a global health technology company that helps people to live longer and more fulfilling lives. Our modular platform enables digital 'hospitals at home' in a variety of disease areas. We power some of the world's most extensive decentralized clinical trials and studies in life sciences. To promote proactive, predictive care and research, our platform combines artificial intelligence, digital biomarkers, and real-world data.